Cargando…
Targeting liver myofibroblasts: a novel approach in anti-fibrogenic therapy
Chronic liver disease results in a liver-scarring response termed fibrosis. Excessive scarring leads to cirrhosis, which is associated with high morbidity and mortality. The only treatment for liver cirrhosis is liver transplantation; therefore, much attention has been directed toward therapies that...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Springer-Verlag
2008
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2716909/ https://www.ncbi.nlm.nih.gov/pubmed/19669316 http://dx.doi.org/10.1007/s12072-008-9093-y |